NCT06952894Completed
Feasibility of RUS Lung in MITS
Feasibility and Efficacy of Surgical Navigation 'RUS Lung' in Patients Undergoing Minimally Invasive Thoracic Surgery (MITS) Segmentectomy for Lung Cancer: a Multicenter Prospective Observational Study With a Propensity-score Matching Analysis
Source: ClinicalTrials.gov · Last updated 3 Sept 2025
Brief summary (registry, in English)
This sponsor-initiated prospective observational study aims to demonstrate the feasibility and efficacy of RUS Lung Surgical Navigation System in patients undergoing minimally invasive thoracic surgery(MITS). The trial will enroll 36 patients who undergo video-assisted or robot-assisted thoracoscopic surgery using RUS Lung. The study will be conducted across two medical centers." * Investigational Medical Device: RUS Lung (Endoscopic Imaging Treatment Planning Software) * Clinical Trial duration: 12 months from IRB approval * Target number of subjects: Total of 36 participants
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 9 Apr 2025
- Start date
- 12 May 2025
- Primary completion date
- 28 May 2025
- Lead sponsor
- Hutom Corp
- Diseases
- Lung cancer
- NCT number
- NCT06952894
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 12 May 2025 to the primary completion date, 28 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Vulnerable subjects
- Individuals who who are not able to undergo CT imaging according to the established protocol
- Individuals who are expected to have severe adhesions
- Individuals who are unable to follow the study procedures and are deemed inappropriate for participation
Who the study is looking for
- Individuals who were diagnosed with lung caner (tumor size≤3cm)
- Individuals aged 19 or older
- Individuals who who are able to undergo CT imaging according to the established protocol
- Individuals who have voluntarily given written consent to participate in this clinical trial
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Severance hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.